AM-630
CAS No. 164178-33-0
AM-630( AM 630 | AM630 | 6-Iodopravodoline )
Catalog No. M12488 CAS No. 164178-33-0
A potent and selective inverse agonist for the cannabinoid receptor CB2 with Ki of 32.1 nM, 165-fold selectivity over CB1.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 101 | In Stock |
|
| 2MG | 44 | In Stock |
|
| 5MG | 64 | In Stock |
|
| 10MG | 92 | In Stock |
|
| 25MG | 210 | In Stock |
|
| 50MG | 338 | In Stock |
|
| 100MG | 538 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAM-630
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent and selective inverse agonist for the cannabinoid receptor CB2 with Ki of 32.1 nM, 165-fold selectivity over CB1.
-
DescriptionA potent and selective inverse agonist for the cannabinoid receptor CB2 with Ki of 32.1 nM, 165-fold selectivity over CB1; inhibits forskolin-stimulated cyclic AMP production in CB1-transfected cells (22.6% at 1 uM and 45.9% at 10 uM).
-
In Vitro——
-
In Vivo——
-
SynonymsAM 630 | AM630 | 6-Iodopravodoline
-
PathwayGPCR/G Protein
-
TargetCannabinoid Receptor
-
RecptorCannabinoid Receptor
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number164178-33-0
-
Formula Weight504.4
-
Molecular FormulaC23H25IN2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(C1=C(C)N(CCN2CCOCC2)C3=C1C=CC(I)=C3)C4=CC=C(OC)C=C4
-
Chemical Name[6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl)-methanone
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Taranabant (1R,2R) s...
A diastereomer form of Taranabant, which is a potent, selective and orally active cannabinoid-1 receptor (CB1R) inverse agonist
-
Otenabant
A potent, and selective CB1 receptor antagonist with Ki of 0.7 nM/0.12 nM in binding and functional assays respectively; has low affinity (Ki=7600 nM) for human CB2 receptors; reverses cannabinoid agonist mediated responses, reduces food intake, and increases energy expenditure and fat oxidation in rodents.ObesityPhase 3 Discontinued
-
CB2R PAM
CB2R PAM is an orally active cannabinoid type 2 receptor (CB2Rs) positive allosteric modulator that enhances CP 55940 and 2-Arachidonylglycerol-stimulated [35S]GTPγS binding to CB2 receptors without affecting receptor activity in the absence of agonists.
Cart
sales@molnova.com